Subscribe to RSS
DOI: 10.1055/s-2007-1010616
Site and Size of Bleeding Peptic Ulcer. Is there any Relation to the Efficacy of Hemostatic Sclerotherapy?
Publication History
Publication Date:
17 March 2008 (online)
![](https://www.thieme-connect.de/media/endoscopy/199102/lookinside/thumbnails/10.1055-s-2007-1010616-1.jpg)
Summary
In 78 patients with high-risk bleeding peptic ulcers (either with active bleeding or non-bleeding visible vessel) endoscopic hemostasis by injection of adrenaline and polidocanol was attempted. Sclerotherapy was performed in 70 (90 %) patients. Initial hemostasis was achieved in 35 (94.5 %) patients with active bleeding, and permanent hemostasis in 61 (87 %). Efficacy of injection therapy was significantly lower in ulcers larger than 2 cm (p = 0.001), and in those located on the posteroinferior duodenal wall (p = 0.03). It was not possible to perform endoscopic injection in 8 (10 %) patients due to difficulty of access, lesions located mainly high on the lesser gastric curvature and on the posteroinferior duodenal wall. From these results we conclude that endoscopic injection is a very useful technique for the initial treatment of high-risk bleeding peptic ulcer, although the size and anatomical location of the lesions may be a limitation of its use.
Key words:
Endoscopicinjection - Size - Location - High-risk bleeding peptic ulcer